Elevate Health review

What it is

Elevate Health, operating as Elevate Health and Wellness LLC, is a medical weight-loss telehealth service selling compounded semaglutide and compounded tirzepatide alongside brand-name Zepbound, with B12, glutathione and NAD⁺ offered as add-ons. Its own description of the corporate structure is that it is a patient management platform providing administrative support to physicians contracted by MDIntegrations and TelegraMD. It advertises all supplies included, Affirm and Klarna payment plans on its longer terms, and a full refund if you are not approved for treatment.

How it works

Provider-guided weight-loss care with ongoing check-ins, where the NAD⁺ sits as an accessory rather than a treatment line of its own. That distinction is the whole assessment for this board. An add-on attached to a GLP-1 plan is not something you can dose, titrate, monitor or evaluate independently — it is bundled into a weight-loss relationship, and if the GLP-1 plan ends the NAD⁺ pathway is not separately defined. The company is clearer than its record suggested about who prescribes: physicians are contracted through MDIntegrations and TelegraMD, both named on the site, which is more than many competitors disclose even if both are shared third-party networks used across many brands. The gaps are still substantial: the compounding pharmacies are described only as state-licensed and are not named, no state list is published, no LegitScript certification is displayed, and there is no standalone Terms of Service page — only privacy, HIPAA and safety-information pages. The full refund if you are not approved is a genuinely good structure and worth crediting, since it removes the risk of paying to be declined.

Pricing transparency

No NAD⁺ price is published anywhere, so we are not quoting one — and on a product sold as an add-on that absence matters more than usual, because you cannot tell whether it adds ten dollars or two hundred to a monthly bill. What Elevate publishes is its GLP-1 ladder, and the shape of it is the thing to notice: compounded semaglutide at $299 a month month-to-month, falling to $232 on three months, $183 on six and $158 on twelve; compounded tirzepatide at $399 falling to $296, $269 and $248 on the same terms. Read plainly, the month-to-month price is high and the advertised low rates require a twelve-month commitment, with Affirm and Klarna financing offered across the longer plans. Those are weight-loss prices and tell you nothing about NAD⁺. Ask what the NAD⁺ add-on costs monthly, what dose and route it supplies, whether it is tied to the plan length you choose, and what happens to it if you stop the GLP-1.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Elevate does display the disclaimer directly — its own copy states that compounded medications are not FDA-approved and that treatment decisions are made solely by a licensed healthcare provider — which is more than several competitors on this board manage. Its pharmacies are described as state-licensed but are not named, and compounded sterile products are not FDA-reviewed for purity and potency the way approved drugs are. On the evidence, the NAD⁺ framing needs answering directly rather than softened. It is marketed here for "energy and longevity", and there are no controlled human outcome trials supporting either claim for injected NAD⁺; the single human intravenous study was a pharmacokinetic pilot that found infused NAD⁺ clears from plasma quickly. The NAD⁺ evidence that exists sits with the oral precursors NR and NMN, which reliably raise blood NAD⁺ in controlled studies — a raised biomarker, not a demonstrated clinical outcome. Glutathione, also sold as an add-on here, has essentially no controlled human outcome evidence either. The GLP-1 side is a different matter: compounded semaglutide and tirzepatide target well-studied pathways though the compounded versions are not FDA-approved, and the brand-name Zepbound it also offers is an approved product. Individual results vary.

Pros and watch-outs

The evidence behind what Elevate Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

How Elevate Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• TNTru Niagen

  The most clinically-studied oral NAD⁺ precursor (NR)

  See Tru Niagen →
• RBRenue By Science

  Liposomal/sublingual NMN with posted lab testing

  See Renue By Science →
• CareBareRX

  Inclusive, no-insurance telehealth with oral and injectable GLP-1 options

  See CareBareRX →